Advertisement

Salix Pharmaceuticals Company Profile

10:32 EDT 18th May 2013 | BioPortfolio

Salix Pharmaceuticals is dedicated to being the leading specialty pharmaceutical company providing products to gastroenterologists and their patients. In-license selective late-stage/marketed products Our "search and development" efforts are designed to identify and acquire late-stage and/or marketed proprietary pharmaceutical products for the treatment of gastrointestinal disease that have an existing base of safety and efficacy data. This focus on late-stage products serves to reduce the risk, time and expense Salix invests in products compared to the investment typically associated with the research and early development phases of pharmaceutical products.

Location

1700 Perimeter Park Drive
Morrisville
NC
27560-8404
United States of America

Contact

Phone: 919-862-1000
Fax: 919-862-1095


News Articles [ 64 Associated News Articles listed on BioPortfolio]

Salix gains new rights as rifaximin deal with Alfa restructured

Salix Pharmaceuticals is again seeking new lines of revenue from its top-selling product, Xifaxan (rifaximin) for traveller's diarrhoea and hepatic encephalopathy, most recently by renegotiating with...

Salix: FDA again extends review of diarrhea drug

Salix Pharmaceuticals Ltd. said Wednesday that the Food and Drug Administration will need until early 2013 to complete a review of crofelemer, a drug that is designed to treat diarrhea in patients ta...

Salix and Alfa Wassermann expand rifaximin accord

USA-based Salix Pharmaceuticals (Nasdaq: SLXP) and Italy's Alfa Wassermann have entered into an exclusive agreement by which Salix has licensed rights in the USA and Canada to an extended intestinal r...

Salix says FDA approves diarrhea drug Fulyzaq

Salix Pharmaceuticals Ltd. said Wednesday that the Food and Drug Administration approved its drug Fulyzaq, which is designed to treat diarrhea in patients taking HIV and AIDS drugs. Its shares rose m...

Salix HIV diarrhea drug hit with 2nd delay

Investors on 5 September didn't overreact, but certainly weren't happy, about the news that the US FDA was delaying for the second time its decision on whether it would approve Salix Pharmaceuticals...

FDA approves crofelemer

FDA approved Fulyzaq crofelemer from Salix Pharmaceuticals Inc. (NASDAQ:SLXP) to treat non-infectious diarrhea in HIV/AIDS patients on antiretroviral therapy. Salix said it is still determining the pr...

Salix Pharmaceuticals to Present at BofA Merrill Lynch 2013 Health Care Conference

Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) today announced that the Company will present at the BofA Merrill Lynch 2013 Health Care Conference in Las Vegas, NV on Tuesday, May 14 a...

FDA Asks Salix for More Info on Constipation Treatment

Shares of Salix Pharmaceuticals sank Monday before markets opened in the first trading day since regulators asked the drug developer for more clinical data on its constipation treatment.

PubMed Articles [ 12 Associated PubMed Articles listed on BioPortfolio]

Correspondence of ectomycorrhizal diversity and colonisation of willows (Salix spp.) grown in short rotation coppice on arable sites and adjacent natural stands.

Willows (Salix spp.) are mycorrhizal tree species sometimes cultivated as short rotation coppice (SRC) on arable sites for energy purposes; they are also among the earliest plants colonising primary s...

Weak habitat specificity in ectomycorrhizal communities associated with Salix herbacea and Salix polaris in alpine tundra.

This study explores mid-alpine ectomycorrhizal communities on Salix herbacea and Salix polaris in plant communities differing in nutrient status and snow conditions. Plant species were identified by t...

Dimeric procyanidins: screening for B1 to B8 and semisynthetic preparation of B3, B4, B6, And B8 from a polymeric procyanidin fraction of white willow bark (Salix alba).

Fifty-seven samples have been analyzed with regard to the occurrence of dimeric procyanidins B1-B8 as well as the composition of polymeric procyanidins. Fifty-two samples were found to contain polymer...

Expression profile of miRNAs in Populus cathayana L. and Salix matsudana Koidz under salt stress.

Soil salinization can lead to environmental and ecological problems worldwide. Abiotic stressors, including salinity, are suspected to regulate microRNA (miRNA) expression. Plants exposed to such abio...

Willow volatiles influence growth, development, and secondary metabolism in Aspergillus parasiticus.

Aflatoxin is a mycotoxin and the most potent naturally occurring carcinogen in many animals. Aflatoxin contamination of food and feed crops causes a significant global burden on human and animal healt...

Clinical Trials [ 5 Associated Clinical Trials listed on BioPortfolio]

Association of Passiflora Incarnata L; Crataegus Oxyacantha L and Salix Alba L. on Mild and Moderate Anxiety

Phase III, multicentric, double blind, randomized study, controlled by Valeriana officinalis for evaluating the efficacy of association of Passiflora incarnata L; Crataegus Oxyacantha L an...

Efficacy and Tolerability Study to Treat Mild and Moderate Anxiety

To evaluate the efficacy and tolerability of the combination use of Passiflora incarnata L, Crataegus oxyacantha and Salix alba L in mild and moderate anxiety. Clinical study phase III, m...

Bioequivalency Study of Balsalazide Capsules Under Fasting Conditions

The objective of this study was to assess bioequivalence of a potential generic 750 mg balsalazide disodium capsule formulation compared with Salix Pharmaceutical's 750 mg balsalazide diso...

A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Balsalazide Disodium 750 mg Capsules Under Fasting Conditions

The objective of this study was to assess the bioequivalence of a potential generic 750 mg balsalazide disodium capsule formulation compared with Salix Pharmaceutical's 750 mg balsalazide...

Fasting Study of Balsalazide Disodium Capsules 750 mg and Colazal® Capsules 750 mg

The objective of this study was to investigate the bioequivalence of Mylan balsalazide disodium 750 mg capsules and Salix Colazal® 750 mg capsules following a single, oral 2250 mg (3 x 75...

Companies [ 6 Associated Companies listed on BioPortfolio]

Salix Pharmaceuticals, Ltd. Salix Pharmaceuticals, Ltd.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, NC, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix’s s...

Salix Pharmaceuticals, Inc.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, NC, develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix’s s...

Salix Pharmaceuticals

Salix Pharmaceuticals is dedicated to being the leading specialty pharmaceutical company providing products to gastroenterologists and their patients. In-license selective late-stage/marketed produ...

Salix Pharmaceuticals , Ltd.

Salix Pharmaceuticals, Ltd.

Salix Pharmaceuticals, Ltd., headquartered in Raleigh, N.C., develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. Salix’s...

More Information about "Salix Pharmaceuticals" on BioPortfolio

We have published hundreds of Salix Pharmaceuticals news stories on BioPortfolio along with dozens of Salix Pharmaceuticals Clinical Trials and PubMed Articles about Salix Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Salix Pharmaceuticals Companies in our database. You can also find out about relevant Salix Pharmaceuticals Drugs and Medications on this site too.

Search BioPortfolio:
Advertisement

Corporate Database Quicklinks



Searches Linking to this Company Record

Advertisement